SCHEMBL3294201

SCHEMBL3294201

O=Cc1c(S(=O)(=O)O)cccc1S(=O)(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TTR P02766 2/20 0.47
TDP1 Q9NUW8 3/20 0.42
ALDH1A1 P00352 2/20 0.42
MEN1 O00255 1/20 0.42
KMT2A Q03164 1/20 0.42
MYC P01106 1/20 0.39
TSHR P16473 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
CDK2 P24941 2/20 0.38
FABP4 P15090 1/20 0.38
CCNA2 P20248 1/20 0.38
MAPK14 Q16539 1/20 0.38
NR4A1 P22736 1/20 0.37
PADI4 Q9UM07 1/20 0.37
AURKA O14965 1/20 0.36
AURKB Q96GD4 1/20 0.36
CYP1A2 P05177 2/20 0.36
HSD17B10 Q99714 2/20 0.35
SNCA P37840 2/20 0.35
CHAT P28329 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17982110 0.98 TTR (0.45) TTRTDP1ALDH1A1MEN1KMT2A
SCHEMBL28375176 0.98 TTR (0.45) TTRTDP1ALDH1A1MEN1KMT2A
SCHEMBL428169 0.87 AURKA (0.43) TTRTDP1ALDH1A1MEN1KMT2A
SCHEMBL28565466 0.87 TDP1 (0.42) TTRTDP1ALDH1A1MEN1KMT2A
SCHEMBL24801172 0.85 ERN1 (0.42) TTRTDP1ALDH1A1MEN1KMT2A
SCHEMBL14388231 0.85 MYC (0.42) TTRTDP1ALDH1A1MEN1KMT2A
SCHEMBL3889315 0.82 ALOX15 (0.44) TTRTDP1ALDH1A1TSHRSMN1; SMN2
SCHEMBL11352006 0.82 TTR (0.55) TTRTDP1ALDH1A1MEN1KMT2A
SCHEMBL28032193 0.80 GABRA1 (0.41) TTRTDP1ALDH1A1MEN1KMT2A
SCHEMBL224921 0.79 TDP1 (0.44) TTRTDP1ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7732625-B2 Colorant compounds XEROX CORPORATION (US) 2010-06-08 US claimed
US-7311767-B2 Forming a salt of a liquid phase change ink carrier of stearyl stearamide, an amine substituted Xanthene, acridine, anthracene or thioxanthene chromogen, and a metal salt capable of forming a compound with two chromogens XEROX CORPORATION (US) 2007-12-25 US claimed
US-7033424-B2 Phase change inks XEROX CORPORATION (US) 2006-04-25 US claimed
US-20060021546-A1 Processes for preparing phase change inks XEROX CORPORATION 2006-02-02 US claimed
US-20060020141-A1 Metallized dye XEROX CORPORATION 2006-01-26 US claimed
US-20060016369-A1 PHASE CHANGE INKS XEROX CORPORATION 2006-01-26 US claimed
CN-115057980-A Fluorine-containing sulfonated aromatic polymer, preparation method and application thereof 中国科学院长春应用化学研究所 2022-09-16 CN disclosed
EP-1956054-B1 Phase change ink XEROX CORP (US) 2010-11-24 EP disclosed
US-7732625-B2 Colorant compounds XEROX CORPORATION (US) 2010-06-08 US disclosed
EP-1958993-A1 Phase change inks containing colorant compounds Xerox Corporation (US) 2008-08-20 EP disclosed
EP-1956054-A2 Colorant compounds Xerox Corporation (US) 2008-08-13 EP disclosed
US-20080187664-A1 Phase change inks containing colorant compounds XEROX CORPORATION 2008-08-07 US disclosed
US-20080184910-A1 Mixture of basic dye and wax XEROX CORPORATION 2008-08-07 US disclosed
US-7311767-B2 Forming a salt of a liquid phase change ink carrier of stearyl stearamide, an amine substituted Xanthene, acridine, anthracene or thioxanthene chromogen, and a metal salt capable of forming a compound with two chromogens XEROX CORPORATION (US) 2007-12-25 US disclosed
US-7033424-B2 Phase change inks XEROX CORPORATION (US) 2006-04-25 US disclosed
US-20060021546-A1 Processes for preparing phase change inks XEROX CORPORATION 2006-02-02 US disclosed
US-20060020141-A1 Metallized dye XEROX CORPORATION 2006-01-26 US disclosed
US-20060016369-A1 PHASE CHANGE INKS XEROX CORPORATION 2006-01-26 US disclosed
EP-0487343-B1 Process for preparing a lithographic plate FUJI PHOTO FILM CO LTD (JP) 1999-04-28 EP disclosed
EP-0487343-A1 Process for preparing a lithographic plate Fuji Photo Film Co., Ltd. (JP) 1992-05-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060020141-A1 Metallized dye CDYL, CDY1; CDY1B, CDYL2 TTR 2094/4885TDP1 3338/4885ALDH1A1 1569/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.